Showing results (11-20 of 92) with videos related to
Sort By:
Pageof 10
Leukemia & Lymphoma|April 19, 2021
CAR-T cell persistence in the treatment of leukemia and lymphomaArjun Gupta, Saar GillFrontiers in Oncology|May 22, 2020
CAR T Cells for Acute Myeloid Leukemia: State of the Art and Future DirectionsSherly Mardiana, Saar GillHematology/Oncology Clinics of North America|July 13, 2023
Chimeric Antigen Receptor T Cells in Acute Myeloid LeukemiaKatherine Cummins, Saar GillExpert Opinion on Biological Therapy|February 3, 2015
How to train your T cell: genetically engineered chimeric antigen receptor T cells versus bispecific T-cell engagers to target CD19 in B acute lymphoblastic leukemiaMarco Ruella, Saar GillLeukemia & Lymphoma|September 14, 2017
Anti-CD123 chimeric antigen receptor T-cells (CART): an evolving treatment strategy for hematological malignancies, and a potential ace-in-the-hole against antigen-negative relapseKatherine D Cummins, Saar GillExpert Opinion on Biological Therapy|November 23, 2013
CAR-modified anti-CD19 T cells for the treatment of B-cell malignancies: rules of the roadSaar Gill, David L PorterImmunological Reviews|December 17, 2014
Going viral: chimeric antigen receptor T-cell therapy for hematological malignanciesSaar Gill, Carl H JuneAnnual Review of Medicine|November 6, 2012
Reduced-intensity hematopoietic stem cell transplants for malignancies: harnessing the graft-versus-tumor effectSaar Gill, David L PorterCurrent Opinion in Hematology|September 14, 2020
Advances in chimeric antigen receptor T cellsOfrat Beyar-Katz, Saar GillPageof 10